FDA Clearance Tracker · K223608
GEM Premier 7000 with IQM3
Last checked: Nov 20, 2026Latest source record: Aug 10, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Aug 10, 2023
Substantially Equivalent
Time to decision
251 days
Received Dec 2, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K223608
- Device name
- GEM Premier 7000 with IQM3
- Applicant
- Instrumentation Laboratory Company
- Applicant location
- Bedford, MA
- Received
- Dec 2, 2022
- Decided
- Aug 10, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1120
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CHL. The earliest in FDA's data is K760229, decided Aug 26, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K223608
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Instrumentation Laboratory Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230852 · Decided Dec 13, 2023 · 260 days after receipt
Device type: Test, Qualitative And Quantitative Factor Deficiency (GGP) · Laboratory Medicine & Pathology
- ACL TOP Family 70 Series510(k)
K231031 · Decided Jun 21, 2023 · 71 days after receipt
Device type: Instrument, Coagulation, Automated (GKP) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.